266 related articles for article (PubMed ID: 6549321)
1. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
[TBL] [Abstract][Full Text] [Related]
2. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
3. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
5. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
7. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
10. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
11. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
12. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
Bronz L; Genton CY; Kunz J; Schreiner WE
Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
[TBL] [Abstract][Full Text] [Related]
13. The role of surgery and treatment trends in uterine sarcoma.
Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
[TBL] [Abstract][Full Text] [Related]
14. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
Dusenbery KE; Potish RA; Judson P
Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
[TBL] [Abstract][Full Text] [Related]
15. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract][Full Text] [Related]
16. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
Liao Q; Wang J; Han J
Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
[TBL] [Abstract][Full Text] [Related]
19. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]